vs
GREENLIGHT CAPITAL RE, LTD.（GLRE）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
GREENLIGHT CAPITAL RE, LTD.的季度营收约是REPLIGEN CORP的1.1倍（$210.3M vs $197.9M），GREENLIGHT CAPITAL RE, LTD.净利率更高（23.4% vs 6.7%，领先16.7%），GREENLIGHT CAPITAL RE, LTD.同比增速更快（48.3% vs 13.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 4.8%）
绿光资本再保险有限公司关联的绿光资本是1996年由大卫·艾因霍恩创立的美国对冲基金，主要投资北美公开交易的企业债务产品与股票，因2008年雷曼兄弟破产前做空其股票、2012年1月在英国因内幕交易被罚1100万美元而受到市场关注，艾因霍恩至今仍担任该基金管理人。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
GLRE vs RGEN — 直观对比
营收规模更大
GLRE
是对方的1.1倍
$197.9M
营收增速更快
GLRE
高出34.6%
13.6%
净利率更高
GLRE
高出16.7%
6.7%
两年增速更快
RGEN
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $210.3M | $197.9M |
| 净利润 | $49.3M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 23.4% | 6.7% |
| 营收同比 | 48.3% | 13.6% |
| 净利润同比 | 279.7% | 143.9% |
| 每股收益（稀释后） | $1.43 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLRERGEN
| Q4 25 | $210.3M | $197.9M | ||
| Q3 25 | $146.1M | $188.8M | ||
| Q2 25 | $160.1M | $182.4M | ||
| Q1 25 | $213.3M | $169.2M | ||
| Q4 24 | $141.8M | $174.1M | ||
| Q3 24 | $188.0M | $154.9M | ||
| Q2 24 | $174.9M | $154.1M | ||
| Q1 24 | $191.3M | $151.3M |
净利润GLRERGEN
| Q4 25 | $49.3M | $13.3M | ||
| Q3 25 | $-4.4M | $14.9M | ||
| Q2 25 | $329.0K | $14.9M | ||
| Q1 25 | $29.6M | $5.8M | ||
| Q4 24 | $-27.4M | $-30.3M | ||
| Q3 24 | $35.2M | $-654.0K | ||
| Q2 24 | $8.0M | $3.3M | ||
| Q1 24 | $27.0M | $2.1M |
毛利率GLRERGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率GLRERGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率GLRERGEN
| Q4 25 | 23.4% | 6.7% | ||
| Q3 25 | -3.0% | 7.9% | ||
| Q2 25 | 0.2% | 8.2% | ||
| Q1 25 | 13.9% | 3.4% | ||
| Q4 24 | -19.3% | -17.4% | ||
| Q3 24 | 18.7% | -0.4% | ||
| Q2 24 | 4.6% | 2.2% | ||
| Q1 24 | 14.1% | 1.4% |
每股收益（稀释后）GLRERGEN
| Q4 25 | $1.43 | $0.24 | ||
| Q3 25 | $-0.13 | $0.26 | ||
| Q2 25 | $0.01 | $0.26 | ||
| Q1 25 | $0.86 | $0.10 | ||
| Q4 24 | $-0.78 | $-0.55 | ||
| Q3 24 | $1.01 | $-0.01 | ||
| Q2 24 | $0.23 | $0.06 | ||
| Q1 24 | $0.78 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $111.8M | $767.6M |
| 总债务越低越好 | $4.7M | $542.2M |
| 股东权益账面价值 | $708.0M | $2.1B |
| 总资产 | $2.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资GLRERGEN
| Q4 25 | $111.8M | $767.6M | ||
| Q3 25 | $68.8M | $748.7M | ||
| Q2 25 | $82.4M | $708.9M | ||
| Q1 25 | $47.5M | $697.2M | ||
| Q4 24 | $64.7M | $757.4M | ||
| Q3 24 | $54.6M | $784.0M | ||
| Q2 24 | $52.2M | $809.1M | ||
| Q1 24 | $61.6M | $780.6M |
总债务GLRERGEN
| Q4 25 | $4.7M | $542.2M | ||
| Q3 25 | $34.7M | $537.9M | ||
| Q2 25 | $58.9M | — | ||
| Q1 25 | $59.8M | — | ||
| Q4 24 | $60.7M | $525.6M | ||
| Q3 24 | $62.6M | — | ||
| Q2 24 | $61.6M | — | ||
| Q1 24 | $72.5M | — |
股东权益GLRERGEN
| Q4 25 | $708.0M | $2.1B | ||
| Q3 25 | $658.9M | $2.1B | ||
| Q2 25 | $663.3M | $2.1B | ||
| Q1 25 | $666.8M | $2.0B | ||
| Q4 24 | $635.9M | $2.0B | ||
| Q3 24 | $663.4M | $2.0B | ||
| Q2 24 | $634.0M | $2.0B | ||
| Q1 24 | $624.5M | $2.0B |
总资产GLRERGEN
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.1B | $2.9B | ||
| Q2 25 | $2.2B | $2.9B | ||
| Q1 25 | $2.2B | $2.9B | ||
| Q4 24 | $2.0B | $2.8B | ||
| Q3 24 | $2.0B | $2.8B | ||
| Q2 24 | $1.9B | $2.9B | ||
| Q1 24 | $1.9B | $2.8B |
负债/权益比GLRERGEN
| Q4 25 | 0.01× | 0.26× | ||
| Q3 25 | 0.05× | 0.26× | ||
| Q2 25 | 0.09× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.10× | 0.27× | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 2.03× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流GLRERGEN
| Q4 25 | $100.2M | $25.7M | ||
| Q3 25 | $31.2M | $48.1M | ||
| Q2 25 | $68.4M | $28.6M | ||
| Q1 25 | $10.4M | $15.0M | ||
| Q4 24 | $29.5M | $39.2M | ||
| Q3 24 | $41.3M | $49.3M | ||
| Q2 24 | $22.7M | $42.2M | ||
| Q1 24 | $18.0M | $44.7M |
自由现金流GLRERGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率GLRERGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度GLRERGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率GLRERGEN
| Q4 25 | 2.03× | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 208.02× | 1.92× | ||
| Q1 25 | 0.35× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.17× | — | ||
| Q2 24 | 2.85× | 12.70× | ||
| Q1 24 | 0.66× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GLRE
| Other | $124.7M | 59% |
| Innovations | $85.6M | 41% |
RGEN
暂无分部数据
